SIREN : 328581814
EVAFLOR is a French company founded 38 years ago, specialized in the sector Fabrication de parfums et de produits pour la toilette. Based in PARIS (75017), this company of category PME shows in 2024 a revenue of 8.3 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-04-25
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8 315 189 € | 8 438 967 € | 7 821 693 € | 6 498 152 € | 9 062 327 € | 7 376 281 € | 8 439 832 € | 8 504 066 € | 9 450 860 € |
| Net income | 95 028 € | 71 058 € | -354 076 € | 100 956 € | -359 723 € | 108 469 € | 314 488 € | -204 964 € | -308 738 € |
| EBITDA | 114 445 € | 174 935 € | -278 528 € | -3 024 € | 356 735 € | 233 194 € | 627 161 € | -87 510 € | -125 741 € |
| Net margin | 1.1% | 0.8% | -4.5% | 1.6% | -4.0% | 1.5% | 3.7% | -2.4% | -3.3% |
In 2024, EVAFLOR achieves revenue of 8.3 M€. Activity remains stable over the period (CAGR: -1.6%). Slight decline of -1% vs 2023. After deducting consumption (5.1 M€), gross margin stands at 3.2 M€, i.e. a rate of 39%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 114 k€, representing 1.4% of revenue. The operating margin remains fragile, requiring cost vigilance. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 95 k€, i.e. 1.1% of revenue. This profit can be retained or distributed to shareholders.
8 315 189 €
3 227 987 €
114 445 €
91 085 €
95 028 €
1.4%
The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 53%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.0 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 1.9% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment.
0.101%
53.042%
1.855%
0.025
10.8%
In 2024, the debt ratio of EVAFLOR (0.10) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
In 2024, the financial autonomy of EVAFLOR (53.0%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
In 2024, the repayment capacity of EVAFLOR (0.03) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 202.23. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 20.0x. Operating income very largely covers interest expenses: high safety margin.
202.23
20.0
In 2024, the liquidity ratio of EVAFLOR (202.23) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
In 2024, the interest coverage of EVAFLOR (20.0x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 133 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 142 days. Favorable situation: supplier credit is longer than customer credit by 9 days. Inventory turnover is 108 days (= Average inventory / Cost of goods x 360). This high level ties up cash and potentially creates obsolescence risk. Overall, WCR represents 254 days of revenue, i.e. 5.9 M€ to permanently finance. Notable WCR improvement over the period (-26%), freeing up cash.
5 862 957 €
133 j
142 j
108 j
254 j
Based on 74 transactions of similar company sales
(all years),
the value of EVAFLOR is estimated at
320 001 €
(range 194 253€ - 786 415€).
With an EBITDA of 114 445€, the sector multiple of 0.6x is applied.
The price/revenue ratio is 0.11x
(conservative valuation).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 74 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare EVAFLOR with other companies in the same sector:
Voir toutes les statistiques du secteur Fabrication de parfums et de produits pour la toilette
The revenue of EVAFLOR in 2024 is 8.3 M€.
Yes, EVAFLOR generated a net profit of 95 k€ in 2024.
The headquarters of EVAFLOR is located in PARIS (75017), in the department Paris.
The tax return of EVAFLOR is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
EVAFLOR operates in the sector Fabrication de parfums et de produits pour la toilette (NAF code 20.42Z). See the 'Sector positioning' section above to compare the company with its competitors.